MorphoSys and G7 Therapeutics Sign Alliance to Develop Antibody Therapeutics
Collaboration Broadens MorphoSys' Capabilities to Target Novel Antigen Classes
06-Aug-2015 -
MorphoSys AG and G7 Therapeutics AG announced that they have signed an agreement to collaborate on novel antibody therapeutics targeting G protein-coupled receptors (GPCRs) and potentially other disease-related transmembrane proteins such as ion channels. Under the terms of the agreement, G7 ...
antibodies
collaborations
G protein-coupled receptors